Bicycle Therapeutics Ltd, a new Medical Research Council (MRC) spin-out, seeking to merge best aspects of small molecules and biologics, secures seed funding from top venture capital firms.
London, UK, 6th October 2009 - Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the creation of a new generation of biotherapeutics, has secured seed funding from Atlas Venture and Novartis Venture Fund, Bicycle Therapeutics combines the most desirable features of small molecules and biologics, to create highly specific and highly stable drugs.
